These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 9482414)
21. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058 [TBL] [Abstract][Full Text] [Related]
22. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]. Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341 [TBL] [Abstract][Full Text] [Related]
23. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors. Tanaka K; Matsunobu T; Sakamoto A; Matsuda S; Iwamoto Y J Orthop Sci; 2002; 7(4):477-82. PubMed ID: 12181663 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Oberlin O; Deley MC; Bui BN; Gentet JC; Philip T; Terrier P; Carrie C; Mechinaud F; Schmitt C; Babin-Boillettot A; Michon J; Br J Cancer; 2001 Nov; 85(11):1646-54. PubMed ID: 11742482 [TBL] [Abstract][Full Text] [Related]
25. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H; J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150 [TBL] [Abstract][Full Text] [Related]
26. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Grier HE Pediatr Clin North Am; 1997 Aug; 44(4):991-1004. PubMed ID: 9286296 [TBL] [Abstract][Full Text] [Related]
27. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92. Schuck A; Hofmann J; Rübe C; Hillmann A; Ahrens S; Paulussen M; Jürgens H; Dunst J; Willich N Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1001-6. PubMed ID: 9869222 [TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli. Bacci G; Ferrari S; Bertoni F; Donati D; Bacchini P; Longhi A; Brach Del Prever A; Forni C; Rimondini S J Clin Oncol; 2000 Feb; 18(4):885-92. PubMed ID: 10673532 [TBL] [Abstract][Full Text] [Related]
30. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. Evans RG; Nesbit ME; Gehan EA; Garnsey LA; Burgert O; Vietti TJ; Cangir A; Tefft M; Thomas P; Askin FB J Clin Oncol; 1991 Jul; 9(7):1173-80. PubMed ID: 2045857 [TBL] [Abstract][Full Text] [Related]
31. Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report. Liu YC; Yeh TC; Wu PS; Sheu JC; Lee HC; Yeung CY; Jiang CB; Liu HC; Hou JY; Chan WT Medicine (Baltimore); 2022 Nov; 101(47):e31752. PubMed ID: 36451511 [TBL] [Abstract][Full Text] [Related]
32. Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group. Daecke W; Ahrens S; Juergens H; Martini AK; Ewerbeck V; Kotz R; Winkelmann W; Bernd L J Cancer Res Clin Oncol; 2005 Apr; 131(4):219-25. PubMed ID: 15614525 [TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366 [TBL] [Abstract][Full Text] [Related]
34. The Ewing's sarcoma family of tumors: Ewing's sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue. Granowetter L; West DC Cancer Treat Res; 1997; 92():253-308. PubMed ID: 9494764 [No Abstract] [Full Text] [Related]
35. Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor. Ehrlich Y; Beck SDW; Ulbright TM; Cheng L; Brames MJ; Andreoiu M; Foster RS; Einhorn LH Ann Oncol; 2010 Sep; 21(9):1846-1850. PubMed ID: 20231305 [TBL] [Abstract][Full Text] [Related]
36. Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP). Deméocq F; Oberlin O; Benz-Lemoine E; Boilletot A; Gentet JC; Zucker JM; Behar C; Poutard P; Olive D; Brunat-Mentigny M Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S45-7. PubMed ID: 2667789 [TBL] [Abstract][Full Text] [Related]
37. Extraskeletal Ewing's sarcoma. Ahmad R; Mayol BR; Davis M; Rougraff BT Cancer; 1999 Feb; 85(3):725-31. PubMed ID: 10091746 [TBL] [Abstract][Full Text] [Related]